Innovation intellectual property protection

Ideas and staying power alone will not guarantee success. After all, this is a competitive industry. To deliver sustained value creation, an innovation strategy must factor in effective intellectual property protection. Merck has pursued an aggres-... 

As these processes continue to develop, we also expect to see new modes of cooperation between academia, research institutes, and industry. New and innovative intellectual property (IP) arrangements may be necessary to protect the IP in a fair manner while enabling quick technology transfer and commercial... 

Over the last decade, these two technologies have matured into a pattern into which most innovations needing protection can be nestled. Hybridoma technology is the simpler of the two to handle in terms of the parameters of intellectual property protection, and perhaps the less applicable to agricultural products. The technology is by now familiar to most, at least in broad outline its applicability is really confined to vertebrate species and has to... 

Keywords Reverse engineering Scanning methods Shape reconstmction Feature reconstmction Innovative design Intellectual property protection... 

Kejrwords Product innovation Virtual product creation Knowledge-based engineering KBE Intellectual property protection IPP Patent infringement... 

Basant, R. (2010) Intellectual Property Protection, Regulation and Innovation in Developing Economies-The Case of Indian Pharmaceutical Industry, Indian Institute of Management-Ahmedabad, Working Paper Series. 

Patents are the most important and strongest type of intellectual property. Patents protect inventions or technical innovations. Patents do not protect new designs (these are protected by copyright or registered designs), nor do... 

These three examples illustrate market-driven research that requires substantial fundamental research to generate the new knowledge that can, in turn, generate intellectual property and provide protection in a long-term market position. I would now like to focus on three critical success factors paramount for rapid innovation from basic research to the marketplace—the three P s. 

This rapidly growing market is very competitive. Companies in this area must be highly innovative to be successful. There are key determinant factors that should be optimized for competitive innovation (a) product development should be shortened by accelerating clinical trials (b) well-protected intellectual property should be built and maintained (c) the efficacy of products should be increased, for example, through new formulations, conjugation, or pegylation (d) drug delivery should be... 

Indeed, for a number of years, it was widely believed that branded biopharmaceuticals were unhkely ever to be threatened by lower-priced, post-patent expiry versions of the products because they are too sensitive and sophisticated to copy safely (see also Part Vll, Chapter 4). The intellectual property is complicated, and could be protected by an extensive array of composition and process-related patents that would extend patent lifetimes practically indefinitely. Moreover, it was widely understood that biopharmaceutical product safety and potency profiles are often exquisitely sensitive to the parameters of the production and purification processes used, and small fluctuations in process specs can result in substantially different biologic activity and immunogenicity. To produce a close copy of such a product, near-exact replication of the innovator company s process may be required. However, biopharmaceutical companies have often chosen to exclude the details in patent filings, preferring to maintain exact process specifications as closely guarded... 

As a result of the national scope of many intellectual property laws, problems sometimes develop where inventions, such as biopharmaceuticals, are traded internationally. International trade can bring divergent national legislation into conflict. Countries that are net exporters of innovations protected by IPRs, such as the United States, the European Union, and Japan, advocate strongly in the international arena for the strengthening of national intellectual property laws and international harmonization of these laws [46]. Although international harmonization... 

---